Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Think of it as a partnership
Dose selection in the research literature varies with the application: musculoskeletal-injury studies commonly report 200250 g twice daily near the affected site, while gastrointestinal-focused protocols use 250500 g once or twice daily, subcutaneously
Some sites may require you to agree to their terms of use and privacy policy
Recently, DPP-4 inhibitors have increasingly replaced sulfonylureas as second line therapy after metformin failure and many metformin/DPP-4 inhibitor fixed dose combinations are available
Diabetes Obes Metab 9:175-185, 2007
US$ 24.65
US$ 27.69
US$ 25.92
US$ 21.83
US$ 24.66
US$ 20.69
